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Dear Editor,
Approximately 40% of children with cerebral palsy (CP)
suffer from drooling, and it is considered severe in 15%.1
Drooling is caused by a combination of several factors such
as diminished awareness to swallow, poor posture and
dysfunctional oral motor functions.2
We distinguish between anterior and posterior drool-
ing. Anterior drooling is characterised by saliva spilled
from the mouth that is clearly visible. Posterior drooling
is defined as the spill of saliva over the tongue through
the oropharyngeal isthmus, causing aspiration and asso-
ciated pneumonias.3
Morbidity due to drooling has been widely described.
Different therapies have been reviewed,4,5 but there is no
consensus regarding the optimal treatment strategy.
Surgical interventions are indicated when conservative
measurements have failed, when a more long-term
solution is desirable or when conservative measurements
are not expected to improve drooling, for example in
older patients or patients suffering from a progressive
disease.
In individuals with combined anterior and posterior
drooling, submandibular duct relocation is contraindicated.
Bilateral submandibular gland excision may be an effective
procedure instead. Previous studies regarding the efficacy of
this procedure were based on small and heterogeneous
populations.4–6 In particular, no validated objective mea-
surements were used. A previous meta-analysis compared
different surgical intervention methods, but did not include
studies on submandibular gland excision without parotid
duct rerouting or ligation.5
We aim to be the first to provide both objective and
subjective results of bilateral submandibular gland excision
in young people with neurological disabilities who drool due
to severe dysphagia.
Materials and methods
Ethical considerations
The research was conducted in accordance with national and
international ethical standards. Informed consent was pro-
vided before each intervention.
Study design
We analysed a historic cohort of children and adolescents
who were examined at the Multidisciplinary Saliva Control
Centre of the RadboudUniversityMedical CentreNijmegen,
the Netherlands, between January 2001 and January 2014.
Demographic data were collected preoperatively.
Surgical procedure
For submandibular gland excision, a skin incision of5 cm
in length was made under general anaesthesia, 4 cm below
the border of the mandible. The platysma muscle was
separated and the lower border of the gland exposed. If
necessary, the facial artery was identified and spared if
possible. The lingual nerve and hypoglossal nerve were
identified and spared. After gland excision, a suction
drainage was routinely placed for 1 day. Intracutaneous
resorbable sutures were used.
Participants
Forty-five children and adolescents have undergone
bilateral submandibular gland excision. This decision
was made on expert opinion by our multidisciplinary
team. Subjects were categorised by CP type, having
epilepsy, severity of motor disturbance assessed by the
Gross Motor Function Classification System (GMFCS),
posture, developmental age, ability to eat and type of
drooling (Table 1).
We excluded three cases with posterior drooling only, as
drooling intensity was assessed by measuring visual saliva
loss. In addition, we excluded twelve cases who had
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undergone surgery for drooling prior to our surgery. Three
children were excluded because of incomplete or missing
medical records. In one case, the period between botulinum
toxin-A injection and surgery was <24 weeks. Ultimately, 26
cases were included for analysis.
Variables
Drooling was assessed at baseline and prospectively during
follow-up visits in the outpatient clinic (8 and 32 weeks after
treatment). Drooling intensity was evaluated using the
drooling quotient (DQ), which is a validated, semi-quanti-
tative direct observational method. The DQ is expressed as a
percentage estimated from the ratio of observed drooling
episodes and the total number of observations (DQ
[%] = 100 9 number of drooling episodes/20).7,8 Success-
ful therapy effect was defined as a higher than 50% reduction
compared to baseline.
Severity of drooling during the prior 2-week period was
scored by a visual analogue scale (VAS) score. Caretakers
assign a drooling score by marking on a line from 0 (= no
drooling) to 100 (= excessive drooling). A reduction of VAS
score of >2 SD from baseline is considered clinically
significant. The Thomas–Stonell and Greenberg classifica-
tion, which consists of a 5-point scale for severity and a 4-
point scale for frequency, was used as a second subjective
score.
Statistical analysis
Descriptive statistics were employed to summarise patient
characteristics. For DQ and VAS, univariate ANOVA with
repeated measures analysis was used. The patient was set as
random factor and time as fixed to evaluate whether
treatment responses differed significantly over time. When
significant, a post hoc pairwise comparison (Fisher’s LSD)
was performed to evaluate differences between means at
different time points. Chi-squared (v2) test was used to
confirm the association between antero-posterior drooling
and recurrent pneumonias based on history. Data were
Table 1. Patient characteristics
Included for analyses
n = 26
Sex, n (%)
Male 13 (50)
Female 13 (50)
Mean age at intervention, year : month (SD)
Submandibular glands excision 16 : 5 (6.69)
Botulinum toxin-A injections 12 : 0 (6.06)
Main diagnosis, n (%)
Spastic CP 11 (45.8)
Spastic/dyskinetic CP 2 (8.3)
Ataxic CP 2 (8.3)
Dyskinetic CP 2 (8.3)
Other developmental disability 7 (29.2)
Missing 2
Developmental age, n (%)
<4 years 20 (87)
4–6, IQ <70 1 (4.3)
>6 year 2 (8.7)
Missing 3
GMFCS level, n (%)
I 1 (4)
II 3 (12)
III 2 (8)
IV 2 (8)
V 17 (68)
Drooling kind, n (%)
Anterior 10 (38.5)
Antero-posterior 16 (61.5)
Epilepsy, n (%)
Controlled 18 (72)
Intractable 2 (8)
No 5 (20)
Missing 1
Head position, n (%)
Anteflexion 6 (24)
Retroflexion 1 (4)
Asymmetrical 7 (28)
Normal 9 (36)
Not registered 3 (8)
History of pneumonia, n (%)
Yes 12 (46.2)
No 14 (53.8)
Use of benzodiazepine, n (%)
No/unknown 24 (92.3)
Yes 2 (7.7)
Table 1. continued
Included for analyses
n = 26
Gastrostomy feeding required, n (%)
Oral + feeding tube 5 (20.8)
Oral 12 (50)
Feeding tube 7 (29.2)
Missing 2
GMFCS: Gross Motor Function Classification System level
descriptions; I: reduced speed, balance and coordination; II:
limitations walking on uneven surfaces and inclines, and in
crowds or confined spaced; III: walking indoors or outdoors on a
level surface with assistance, wheelchair as needed; IV: reliance
on wheelchair; V: no means of independent mobility; CP,
cerebral palsy.
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analysed using SPSS version 20.0 for Windows (SPSS Inc.,
Chicago, IL, USA).
Results
Characteristics of the 26 patients included for analyses are
shown in Table 1. Diagnoses comprised of 17 patients
with CP, two patients with a yet unknown disease and
seven patients with a non-progressive developmental
disability.
Observation and scoring by speech therapists revealed
that a minority of 39% had anterior drooling only,
compared to 61% with antero-posterior drooling. Corre-
lation analyses revealed that 19 of 25 subjects with a
combination of anterior and posterior drooling had
suffered from recurrent pneumonias in the past, while
none of the subjects with anterior drooling alone had
suffered from pneumonia (Chi-squared-test; d.f. 1: value
17.917, P < 0.001). This result was in accordance with the
observations by the speech therapists.
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Fig. 1. (a) Drooling frequency score, marked by caregivers before and after surgery. (b) Drooling severity score, marked by caregivers before
and after surgery
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The average age at the time of surgery was 15.6 years (SD
6.72, range 2–38 years). Two subjects were transferred to the
intensive care unit, due to bleeding requiring reoperation.
One case of xerostomia was reported. No procedures
resulted in damage of the marginal branch of the facial
nerve, lingual nerve or hypoglossal nerve.
Subjective outcomes based on the Thomas–Stonell and
Greenberg classification are shown in Fig. 1. At baseline,
caregivers had assigned the highest score of 4 for drooling
frequency (defined as ‘constant, always wet’) in 72.7% of
cases. In contrast, at 8 and 32 weeks follow-up, scores lower
than 4 were assigned in 87.5% and 85% of cases, respectively.
Drooling severity was assigned the highest score of 5 (defined
as ‘profuse, hands, clothes and objects wet’) by 68.2% of
caregivers at baseline. At 8 and 32 weeks, this was reduced to
25% and 26.3%, respectively.
Univariate ANOVA with repeated measures analysis
revealed a significant effect of time for both subjective VAS
score (P ≤ 0.001, d.f. 2, F 16,589) and objective DQ
(P = 0.002, d.f. 2, F 7, 498) (Fig. 2). The marginal mean
DQ was reduced from 33.5 at baseline to 17.1 at 8 weeks
(P = 0.008) and to 9.9 at 32 weeks (P = 0.001) following
surgical intervention. The estimated marginal mean VAS
score improved from 75 at baseline to 34.7 after 8 weeks.
Although the mean score was slightly higher (40.5) after
32 weeks, this was still significantly lower than at baseline
(P ≤ 0.001) (Table 2). Based on the treatment success
criteria, 64.7% and 61.5% of subjects had at least a 50%
reduction in DQ at 8 weeks and 32 weeks, respectively.
Success rates based on a VAS score reduction by at least 2 SD
were 55% at 8 weeks and 44% at 32 weeks.
Sample sizes for the analysis of treatment responses varied
from 18 to 23, as we did not impute for missing data.
Discussion
Synopsis of key findings
We demonstrate that bilateral submandibular gland exci-
sion is an effective treatment for drooling, with an overall
response rate of 63%. Subjective outcome measurements
also showed significant improvements following surgery.
We noticed the subjective improvement was slightly less
after 32 weeks, in contrast to the objective results, where
the effect progressed. These differences underline the
importance of the use of standardised objective outcome
measurements.
Comparison with other studies
Prior to surgery, patients have frequently undergone
conservative treatments, with or without success.3–5
For the last decade, botulinum toxin-A injections in one
or more major glands have offered a promising and well-
tolerated treatment option.3,6,9 A recent study by Scheffer
et al.9 using the same objective measurements methods
reported a response rate of 50% after 8 weeks when
injecting the submandibular glands. This is only slightly
lower than our response rate of 64.7% after 8 weeks.
However, the effect of botulinum toxin-A injections fades
after 32 weeks; it remains effective in only 11.3% of cases.
In contrast, bilateral submandibular gland excision
resulted in a response rate of 61.5% at 32 weeks after
surgery. Nevertheless, botulinum toxin-A injections come
with the benefit of limited procedure-based morbidity and
the fact that the temporary nature is expected. This makes
it an attractive procedure in children between 4 and 8–
10 years of age, when ongoing development still might
solve the problem.
Bilateral submandibular gland excision is slightly less
effective compared to submandibular duct relocation
(response rate 81% in our clinic).5,9 Differences in success
rates can be explained by the multivariate causes of
drooling and heterogeneity of the population. Subman-
dibular duct relocation is only performed in those patients
with only anterior drooling and a safe pharyngeal phase of
swallowing. Excision of the submandibular glands is also
performed in those with combined or posterior drooling,
and thus patients with a more pronounced severe
dysphagia. In addition, submandibular duct relocation
may trigger a more frequent swallowing reflex due to
pharyngeal saliva release after surgery. This could explain
differences in success.
Ligation of the salivary ducts has recently gained
popularity.10 As for submandibular glands excision, liga-
tion of the salivary ducts aims to reduce the amount of
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Fig. 2. Estimated marginal mean drooling quotient and visual
analogue scale (VAS) scores during follow-up moments.
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saliva produced. This procedure is attractive because of its
surgical simplicity and because it carries a much lower risk
for unsightly scars or nerve damage. Varying results have
been reported, with response rates up to 73%. Unfortu-
nately, further procedures are frequently required due to
recurrence of drooling.10
Strengths and weaknesses of the study
We are aware of the fact that our group is very
heterogeneous, especially in term of age, nevertheless we
think that this does not influence our results. In addition,
the mental age showed less heterogeneity. Although we
used a small number of subjects and a short period of
follow-up, we did use objective measurements during
follow-up instead of only subjective measurements. Also
long-lasting results are to be expected due to the nature of
the intervention.
In our study, we used stringent exclusion criteria.
Although we collected a historic cohort, all data were
collected prospectively. Specifically, we created a cohort with
an indication for treatment of either anterior or mixed
antero-posterior drooling. This allows our findings to be
more easily compared with future studies and to be clinically
correlated to the follow-up measurements (DQ and VAS
scores).
Conclusion
Our study shows that bilateral submandibular gland excision
significantly reduces drooling in more than half of the
children with a neurological disease. This procedure is
especially attractive for those where submandibular duct
relocation is contraindicated. In our opinion, subsequent
studies should focus on larger sample sizes and posterior
drooling.
Keypoints
• Drooling is a major problem in children and
adolescents with neurological disorders. It has been
suggested that excision of the submandibular glands
may be an effective method for reduction of saliva.
• We analysed a historic cohort of 45 patients who have
undergone submandibular gland excision for moder-
ate-to-severe drooling in our clinic between January
2001 and January 2014. Twenty-six children were
eligible for analysis. Theywere evaluated preoperatively
(baseline) and at 8 and 32 weeks following surgery.
• Drooling intensity was significantly reduced following
surgery compared to baseline. Drooling quotient was
reduced from a baseline score of 33.5 to 17.1 after
8 weeks and 9.9 after 32 weeks (P = 0.002). On the
basis of our success criterion, 63% of surgeries were
successful. Similarly, subjective visual analogue scale
score and drooling severity and frequency scores
showed significant improvement following surgery.
• Bilateral submandibular gland excision is an effective
therapy for drooling in young people with neurological
disabilities, especially when submandibular duct relo-
cation is contraindicated.
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Table 2. Mean differences between baseline and follow-up of drooling quotient and visual analogue scale (VAS)
No. of
observations
Missing
observations
Absolute mean difference
(95% CI)
Relative mean difference
(%)
Significance
(P)
Drooling quotient
Baseline 21 5
8 weeks 21 5 16.37 (4.5–28.2) 49 0.008
32 weeks 18 8 23.58 (10.6–36.5) 70 0.001
Visual analogue scale
Baseline 23 3
8 weeks 21 5 40.23 (25–55.6) 53.70 ≤0.001
32 weeks 19 7 34.45 (18.5–50.4) 46 ≤0.001
The mean difference is significant at the 0.05 level.
CI, confidence interval.
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